Cargando…

Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma

The focus of this commentary is on the attempt to create EQ-5D-3L ordinal preferences from a disease specific asthma questionnaire, the Asthma Quality of Life Questionnaire (AQLQ). The question is whether it is possible from the perspective of fundamental measurement to create a simple linear algori...

Descripción completa

Detalles Bibliográficos
Autor principal: Langley, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836758/
https://www.ncbi.nlm.nih.gov/pubmed/36654713
http://dx.doi.org/10.24926/iip.v13i2.4455
_version_ 1784868933374836736
author Langley, Paul C
author_facet Langley, Paul C
author_sort Langley, Paul C
collection PubMed
description The focus of this commentary is on the attempt to create EQ-5D-3L ordinal preferences from a disease specific asthma questionnaire, the Asthma Quality of Life Questionnaire (AQLQ). The question is whether it is possible from the perspective of fundamental measurement to create a simple linear algorithm to map AQLQ scores to EQ-5D-3L preferences. It is proposed that this is mathematically impossible as the aggregate AQLQ score is ordinal, apart from the fact that the AQLQ is a multiattribute score that lacks construct validity and any pretense to having interval properties. Disallowing the mapped utilities means that the modelling cannot be sustained. It is proposed that the focus should be on single attribute measures of the latent construct “need fulfillment quality of life”. These measures would meet the required standards of Rasch Measurement Theory (RMT) applying simultaneous conjoint standards of measurement theory, as well as capturing the patient voice.
format Online
Article
Text
id pubmed-9836758
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-98367582023-01-17 Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma Langley, Paul C Innov Pharm Commentary The focus of this commentary is on the attempt to create EQ-5D-3L ordinal preferences from a disease specific asthma questionnaire, the Asthma Quality of Life Questionnaire (AQLQ). The question is whether it is possible from the perspective of fundamental measurement to create a simple linear algorithm to map AQLQ scores to EQ-5D-3L preferences. It is proposed that this is mathematically impossible as the aggregate AQLQ score is ordinal, apart from the fact that the AQLQ is a multiattribute score that lacks construct validity and any pretense to having interval properties. Disallowing the mapped utilities means that the modelling cannot be sustained. It is proposed that the focus should be on single attribute measures of the latent construct “need fulfillment quality of life”. These measures would meet the required standards of Rasch Measurement Theory (RMT) applying simultaneous conjoint standards of measurement theory, as well as capturing the patient voice. University of Minnesota Libraries Publishing 2022-12-12 /pmc/articles/PMC9836758/ /pubmed/36654713 http://dx.doi.org/10.24926/iip.v13i2.4455 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Langley, Paul C
Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
title Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
title_full Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
title_fullStr Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
title_full_unstemmed Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
title_short Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
title_sort mapping impossible utilities: the icer report on tezepelumab for severe asthma
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836758/
https://www.ncbi.nlm.nih.gov/pubmed/36654713
http://dx.doi.org/10.24926/iip.v13i2.4455
work_keys_str_mv AT langleypaulc mappingimpossibleutilitiestheicerreportontezepelumabforsevereasthma